Maintenance Olaparib in Elderly Patients With a Germline BRCA Mutation and Metastatic Pancreatic Cancer
Results from an additional analyses of phase III POLO trial by age group presented at ESMO World GI 2020 Virtual
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Results from an additional analyses of phase III POLO trial by age group presented at ESMO World GI 2020 Virtual
Results of the CheckMate 459 study long-term survival outcomes presented at ESMO World GI 2020 Virtual
A comprehensive new edition presents the latest information in early-, intermediate- and advanced-stage hepatocellular carcinoma
It is intended for the treatment of carcinoma of the colon or rectum, breast cancer, NSCLC, RCC, epithelial ovarian cancer, and carcinoma of the cervix
Evidence for efficacy is based on the results from the KEYNOTE-629 trial
More safety data is needed in terms of treatment of symptomatic COVID-19 patients with anticancer drugs
Approval is based on the results from the SADAL trial
Thrombogenicity of primary tumour, immobilisation, chemotherapy, obesity and steroid use are independently associated with venous thromboembolic events
Efficacy and safety were supported by data from the AAML0531 study
FDA also approved the cobas EZH2 Mutation Test as a companion diagnostic for tazemetostat
Efficacy was demonstrated in the PM1183-B-005-14 study
Findings from the MSKCC series
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.